NCT00089206View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

November 30, 2005

Conditions
Intraocular MelanomaMelanoma (Skin)
Interventions
BIOLOGICAL

incomplete Freund's adjuvant

BIOLOGICAL

multi-epitope melanoma peptide vaccine

BIOLOGICAL

sargramostim

Trial Locations (1)

22908

Cancer Center at the University of Virginia, Charlottesville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Virginia

OTHER

NCT00089206 - Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter